Insmed Incorporated (INSM)

NASDAQ: INSM · USD

$97.3

+2.34 (+2.5%)· Recorded snapshot

Market cap	21.2B
Revenue (ttm)	1.1B
Net income (ttm)	-875.3M
EPS (ttm)	-$4.09
Shares out	218.4M
Volume	3,914,958
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): -875.3M
EPS (ttm): -$4.09
Market cap: 21.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-87.2

P25 n/aP50 n/aP75 n/a

ROIC-29.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All INSM indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001104506
Company name	Insmed Incorporated
Country	United States
Country code	US
CUSIP number	457669307
Earnings date	2026-10-29
Earnings time	bmo
Employees	1,664
Employees change	393
Employees growth	30.92%
Enterprise value	$20.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1988
Industry	Biotechnology
IPO date	2000-06-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US4576693075
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2011-03-03
Last stock split type	Reverse
Market cap	$21.2B
Market cap category	Large-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$97.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	INSM
U.S. state	New Jersey
Website	https://www.insmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.2%
EV/Sales	18.21x
FCF / EV yield	-3.9%
FCF yield	-3.82%
Forward EV/Sales	8.52x
Forward P/S	8.69x
P/B ratio	27.36x
P/S ratio	18.58x
Price / tangible book value	38.53x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-71.43%
EBITDA margin	-69.88%
Gross margin	83.46%
Operating margin	-71.43%
Pretax margin	-76.4%
Profit margin	-76.94%
Profit per employee	$-526,028
Revenue per employee	$683,675
ROA	-22.17%
ROA (5Y)	-25.98%
ROCE	-48.84%
ROE	-87.22%
ROIC	-29.14%
SBC / revenue	13.84%
Tax / revenue	0.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	214.97%
Gross profit growth (Q)	351.57%
Gross profit growth 3Y	64.7%
Gross profit growth 5Y	49.19%
Net income growth quarters	2
Net income growth years	0
Revenue growth	185.76%
Revenue growth (Q)	296.11%
Revenue growth (QoQ)	39.06%
Revenue growth 3Y	61.62%
Revenue growth 5Y	46.15%
Revenue growth quarters	22
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-28.7M
Depreciation and amortization	$17.7M
EBIT	$-812.6M
EBITDA	$-795M
EPS	$-4.09
FCF per share	$-3.70
Financing cash flow	$124M
Free cash flow	$-807.7M
Free cash flow minus SBC	$-965.1M
Gross profit	$949.4M
Income taxes	$6.2M
Investing cash flow	$-82.8M
Net borrowing	$-3.1M
Net cash flow	$-739.6M
Net income	$-875.3M
Operating cash flow minus SBC	$-936.4M
Operating income	$-812.6M
Revenue	$1.1B
Stock-based compensation	$157.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	9.79
Book value per share	$3.47
Debt / equity	0.98
Goodwill	$136.1M
Interest coverage	-9.99
Long-term assets	$468.6M
Long-term liabilities	$906.3M
Net cash (debt)	$420.6M
Net cash / market cap	1.99%
Net cash growth	-62.37%
Net debt / equity	-0.56
Piotroski F-Score	3
Property, plant and equipment	$209.8M
Shareholders' equity	$757.5M
Tangible book value	$548.5M
Tangible book value per share	$2.51
Total assets	$2.1B
Total cash	$1.2B
Total debt	$739.7M
Total liabilities	$1.3B
WACC	8.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	$1.6B
Current liabilities	$438.7M
Current ratio	3.72
Inventory turnover	1.51
Net working capital	$44.7M
Quick ratio	3.14
Working capital	$1.2B
Working capital turnover	0.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-18.73%
Dividend yield	0%
Shareholder yield	-18.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	605.6%
10Y return CAGR	21.58%
10Y total return	605.6%
150-day SMA	$117.57
15Y price change	2,455%
15Y return CAGR	24.11%
15Y total return	2,455%
1D price change	2.46%
1M price change	-17.6%
1M total return	-17.6%
1W price change	1.48%
1W total return	1.48%
1Y price change	-40.81%
1Y return CAGR	-40.83%
1Y total return	-40.81%
20-day SMA	$98.95
200-day SMA	$125.93
20Y price change	652.64%
20Y return CAGR	10.62%
20Y total return	652.64%
3M price change	-7.29%
3M total return	-7.29%
3Y price change	306.58%
3Y return CAGR	59.59%
3Y total return	306.58%
50-day SMA	$113.30
50-day SMA vs 200-day SMA	50under200
52-week high	$212.75
52-week high date	2025-12-02
52-week low	$90.39
52-week low date	2026-06-10
5Y price change	267.77%
5Y return CAGR	29.76%
5Y total return	267.77%
6M price change	-28.6%
6M total return	-28.6%
All-time high	$212.75
All-time high date	2025-12-02
All-time low	$2.64
All-time low date	2011-11-25
Average true range (ATR)	$3.69
Average volume	3.2M
Beta (1Y)	0.98
Beta (2Y)	0.9
Beta (5Y)	0.82
Change from 52-week high	-54.27%
Change from 52-week low	7.65%
Change from all-time high	-54.36%
Change from all-time low	3,577.65%
Change from open	3.38%
Day's gap	-0.88%
Dollar volume	$380.9M
High price	$97.91
Low price	$94.12
Monthly RSI	46.77
Open price	$94.12
Position in 52-week range	83.91%
Premarket change	-0.42%
Premarket close	$94.96
Premarket price	$94.56
Premarket volume	2.2K
Previous close	$94.96
Price vs 150-day SMA	-17.42%
Price vs 20-day SMA	-1.88%
Price vs 200-day SMA	-22.9%
Price vs 50-day SMA	-14.3%
Relative volume	1.24
RSI	38.38
Sharpe ratio	-0.6
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	0.58
Sortino ratio	-0.8
Sortino ratio (3Y)	2.26
Sortino ratio (5Y)	1.41
Volume	3.9M
Weekly RSI	39.48
YTD price change	-44.21%
YTD total return	-44.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216.9M
Float percentage	99.34%
Shares change (QoQ)	0.87%
Shares change (YoY)	18.73%
Shares held by insiders	0.62%
Shares held by institutions	104.58%
Shares outstanding	218.4M
Short % of float	6.36%
Short % of shares	6.32%
Short ratio	6.5 days

Deeper analysis on INSM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this INSM report

Is a complete INSM research report available?

No complete published report is available for Insmed Incorporated (INSM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Insmed Incorporated (INSM)

Price

Financial snapshot

Fair-value bridge

Latest news · INSM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INSM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INSM

Frequently asked questions